Drug intelligence / Profile preview

Goldtropfen-W

Development stage
Unknown
Lead developer
Weber & Weber
Modality
Small Molecules
Administration
Oral
01

Overview

Goldtropfen-W is a homeopathic combination medicinal product developed by Weber & Weber Biologische Arzneimittel, traditionally used for the supportive treatment of cardiovascular conditions. The formulation is designed to address symptoms such as nervous heart complaints, circulatory weakness, and age-related decline in cardiac performance. It typically contains a synergistic blend of homeopathic dilutions, including *Crataegus* (Hawthorn), which is recognized for its cardiotonic properties and ability to improve coronary blood flow; *Cactus* (Queen of the Night), used to manage heart rhythm and chest tightness; and *Aurum chloratum natronatum* (Gold sodium chloride), intended to stabilize blood pressure and support overall heart function. As a biological medicine, it aims to stimulate the body's self-regulatory mechanisms to improve cardiovascular resilience.

Brand names
Goldtropfen-W
Other names
Goldtropfen-W Weber & WeberHerz-Kreislauf-Tropfen Weber & Weber

Beyond the preview

Go deeper on Goldtropfen-W.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldtropfen-W.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call